[LB-3] Development of an NGS-based CDx assay for multiple drug targets across solid tumor malignancies

^○細野 直哉¹, Jill Stefanelli², Josh Stahl², Brian Kudlow², Ryan Walters², Laura Griffin², Josh Haimes² (1.Biostream. Co. ltd., 2.ArcherDX, Inc.)

NGSアッセイ、体細胞変異、融合遺伝子